Adisorn Ratanaphan

3PUBLICATIONS
2CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 13, 2025
Combinative Treatment of the PARP Inhibitor Olaparib and Antimetastasis Ruthenium(II)-Arene Compound RAPTA-T for Triple-Negative BRCA1 Wild-Type Breast Cancer Cells.

Adisorn Ratanaphan

|Oct 29, 2025
Therapeutic Potential of Metal-Based and PARP Inhibitor Chemotherapy for BRCA1-Associated Triple-Negative Breast Cancer.

Adisorn Ratanaphan

|Apr 25, 2019
Cellular responses of BRCA1-defective HCC1937 breast cancer cells induced by the antimetastasis ruthenium(II) arene compound RAPTA-T.

Tidarat Nhukeaw, Khwanjira Hongthong, Paul J Dyson

Pageof 1

Frequent Collaborators

1 joint publications

Tidarat Nhukeaw

1 joint publications

Paul J Dyson